Retour sur lavenir.net
   KBC ANCORA 94.400 € (+0,64 %)     TINC 10.960 € (+0,74 %)     ASCENCIO 52.800 € (+0,19 %)     D'IETEREN GROUP 170.200 € (-0,12 %)     TUBIZE-FIN 178.900 € (+0,51 %)     PROXIMUS 6.435 € (+0,86 %)     RECTICEL 12.580 € (0,00 %)     AGEAS 75.800 € (+0,40 %)     AB INBEV 69.220 € (+0,67 %)     DECEUNINCK 2.470 € (+1,23 %)     UCB 210.300 € (+0,19 %)     VGP 72.000 € (+1,41 %)     KBC 132.100 € (+0,84 %)     BEKAERT 37.550 € (+0,67 %)     KINEPOLIS GROUP 49.600 € (+1,22 %)     FAGRON 21.700 € (-0,23 %)     VASTNED 27.950 € (-0,36 %)     AEDIFICA 66.100 € (0,00 %)     ARGENX SE 854.000 € (-0,56 %)     GBL 75.050 € (+0,20 %)     SYENSQO 78.700 € (+1,42 %)     DEME GROUP 181.400 € (+1,00 %)     ELIA GROUP 118.000 € (+1,37 %)     ONTEX GROUP 2.210 € (+2,08 %)     UMICORE 22.020 € (+1,85 %)     BPOST 1.222 € (-0,97 %)     COLRUYT 38.320 € (-1,29 %)     SOFINA 255.600 € (+0,08 %)     AZELIS GROUP 11.970 € (+0,08 %)     IBA 15.400 € (-0,13 %)     ACKERMANS V.HAAREN 273.400 € (+1,48 %)     XIOR 25.350 € (+1,40 %)     BQUE NAT. BELGIQUE 361.000 € (0,00 %)     BARCO 7.420 € (+0,68 %)     CARE PROPERTY INV. 12.300 € (+0,65 %)     MONTEA 64.300 € (+2,39 %)     SOLVAY 26.100 € (+1,01 %)     WDP 20.900 € (+0,58 %)     SHURGARD 22.950 € (+0,66 %)     GIMV 46.450 € (+1,20 %)     MELEXIS 65.300 € (+2,03 %)     IMMOBEL 19.350 € (0,00 %)     ATENOR 1.000 € (+0,40 %)     RETAIL ESTATES 64.100 € (+0,63 %)     FLUXYS BELGIUM D 21.800 € (-1,80 %)     JENSEN-GROUP 75.000 € (-0,27 %)     BREDERODE 105.800 € (+0,38 %)     ONWARD MEDICAL 2.715 € (-0,37 %)     CMB.TECH 16.980 € (0,00 %)     LOTUS BAKERIES 12 120.000 € (-0,16 %)     CIE BOIS SAUVAGE 303.000 € (+1,34 %)     NYXOAH 1.354 € (-1,17 %)     AGFA-GEVAERT 0.385 € (-0,26 %)     SIPEF 107.400 € (0,00 %)     VAN DE VELDE 30.000 € (-0,33 %)     SOLVAC NOM(RETAIL) 82.000 € (0,00 %)     MOURY CONSTRUCT 710.000 € (-0,56 %)     EVS 27.800 € (-0,18 %)     BIOTALYS 2.065 € (+2,48 %)     CAMPINE 185.500 € (-0,80 %)  
   VIRIDIEN 92.950 € (+1,03 %)     ASM INTERNATIONAL 776.600 € (+3,55 %)     ESSILORLUXOTTICA 144.550 € (+0,10 %)     AXA 43.750 € (+0,30 %)     SOCIETE GENERALE 73.740 € (+1,35 %)     SAINT GOBAIN 69.600 € (+0,03 %)     TOTALENERGIES 80.970 € (+0,60 %)     LVMH 406.400 € (-0,01 %)     AIR LIQUIDE 166.700 € (+0,28 %)     SES 4.716 € (+0,34 %)     VINCI 112.200 € (+1,45 %)     CEGEDIM 10.520 € (-0,57 %)     B.COM.PORTUGUES 1.183 € (+0,17 %)     ASML HOLDING 1 416.000 € (+2,70 %)     ACCOR 45.400 € (+0,64 %)     J.MARTINS,SGPS 17.760 € (-0,17 %)     SCHNEIDER ELECTRIC 278.800 € (+1,27 %)     STMICROELECTRONICS 42.885 € (+2,63 %)     AIRBUS 195.860 € (+0,54 %)     EUROFINS SCIENT. 73.820 € (+0,46 %)     ING GROEP N.V. 31.895 € (+0,65 %)     KERING 237.100 € (+1,17 %)     MICHELIN 33.200 € (+0,45 %)     AIR FRANCE -KLM 11.255 € (-0,04 %)     RENAULT 28.340 € (-4,26 %)     BASTIDE LE CONFORT 22.600 € (+0,44 %)     ALSTOM 15.840 € (+1,38 %)     ABN AMRO BANK N.V. 43.100 € (+0,96 %)     VALEO 14.360 € (0,00 %)     ELIOR GROUP 1.921 € (+0,10 %)     AUBAY 53.600 € (+0,37 %)     AHOLD DEL 31.730 € (-0,72 %)     ERAMET 43.520 € (-0,09 %)     SMCP 6.500 € (-0,46 %)     SANOFI 73.890 € (-0,43 %)     ATOS GROUP 25.700 € (+2,07 %)     PHILIPS KON 21.580 € (0,00 %)     BE SEMICONDUCTOR 179.200 € (+1,62 %)     TRANSGENE 0.860 € (-0,12 %)     TEIXEIRA DUARTE 0.482 € (-0,21 %)     ENGIE 23.860 € (+1,06 %)     STELLANTIS NV 4.382 € (-2,35 %)     VALERIO TX 0.630 € (-2,93 %)     BIOPHYTIS 0.046 € (-10,24 %)     2CRSI 28.450 € (+6,95 %)     BONDUELLE 8.200 € (-1,44 %)     PROSUS 35.695 € (-2,06 %)     PERNOD RICARD 60.280 € (-0,79 %)     PARROT 9.260 € (+0,65 %)     EIFFAGE 107.500 € (+1,70 %)     POXEL 0.177 € (-0,56 %)     NANOBIOTIX 29.620 € (-1,79 %)     ADYEN 915.900 € (-1,69 %)     LAKEFRONT BIOTHER. 24.240 € (+1,51 %)     BUREAU VERITAS 27.850 € (+0,25 %)     UMG 14.920 € (+1,60 %)     DASSAULT SYSTEMES 20.630 € (-1,81 %)     ARKEMA 57.200 € (+0,35 %)     CVC CAPITAL 13.010 € (-0,38 %)     UBISOFT ENTERTAIN 5.528 € (-0,11 %)  
News Réglementées
03/01/2023 14:36

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( )
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

03-Jan-2023 / 13:36 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Full name of discloser:

The Vanguard Group, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

 The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

Mediclinic International plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

 For an opening position disclosure, state the latest practicable date prior to the disclosure

29 December 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

18,016,212

2.44%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 TOTAL:

18,016,212

2.44%

 

 

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary

Purchase

2,538

4.98 GBP

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state “none”

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

03 January 2023

Contact name:

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière